Pain is one of the most common reasons adults seek medical care in the United States. According to the Centers for Disease Control and Prevention (CDC), American healthcare providers write 259 million prescriptions for opioid pain medication each yea…
There are signs that the supply chain issues we’ve all witnessed over the past several years have started to subside, offering relief to many. That said, the pharmaceutical industry isn’t entirely out of the woods just yet. Supply chain setbacks have…
The statistics regarding drug use among the American workforce are alarming. Drugs can adversely affect a person’s judgment, reaction time, attentiveness, dexterity, cognitive function, productivity and more. It’s not hard to imagine how an employee …
The statistics regarding drug use among the American workforce are alarming. An estimated one in 12 U.S. workers has a substance use disorder (SUD), and more than half of all adults diagnosed with an SUD are employed full-time. Many more members of t…
More than 900 million units of vehicles, food, drugs, consumer products and medical devices were recalled during the first quarter of 2022. This is the highest number recalled in a single quarter over the past 10 years, as reported in our latest edit…
Has it ever been more important to be mindful, stay present and set a clear path for health and wellness than it is right now? For this year’s RIMS 2020 conference, Sedgwick had planned to invite attendees to join us in the annual Wellness ZENter, a …
As a claims organization, it’s up to us to keep our clients and their customers informed on current issues and deliver peace of mind. The healthcare, product liability and life sciences space is constantly evolving, but we’re keeping an eye on the fo…
On June 14, 2018, the Maine Supreme Judicial Court issued a much-anticipated ruling in Gaetan H. Bourgoin v. Twin Rivers Paper Company, LLC, et al that reversed an order requiring an injured employee to be reimbursed for the cost of medical marijuana…
In late 2011, a team of claims management and managed care leaders at Sedgwick met to identify how they could address the troubling rise in opioid prescriptions and morphine equivalent dosage (MED). What followed was the development of a team…
Early nurse engagement makes a valuable impact in 3 key areas Recent analysis of Sedgwick’s claims data shows that employers using 24/7 clinical consultation for workplace injuries saw 34% lower incurred costs than those using an intake process with…
Sedgwick routinely reminds clients and colleagues about the U.S. Drug Enforcement Administration’s (DEA’s) National Prescription Drug Take Back Days. The next Take Back Day will be Saturday, April 28 from 10 a.m. – 2 p.m. In 2010, the DEA started org…
Claims administrators have an invaluable opportunity to help future pharmacists understand the challenges regarding prescription drug use for occupational injuries. A pharmacist intern program, like the one we offer at Sedgwick, can provide ex…
Sedgwick routinely reminds clients and colleagues about the U.S. Drug Enforcement Administration’s (DEA’s) National Prescription Drug Take Back Days. The next Take Back Day will be this Saturday, October 28 from 10 a.m. – 2 p.m. In 2010, the DEA st…
The 2017 National Prescription Drug Take-Back Day is Saturday, April 29 from 10:00 a.m. – 2:00 p.m. The day was established in 2010 by the U.S. Drug Enforcement Administration (DEA) to help reduce prescription drug risks and promote safety. Accord…
State governments are responding to the opioid epidemic. Recently, the New Jersey governor signed new legislation that limits prescribers’ capacity to provide first-time opioid prescriptions for more than five days. The New Jersey state senate passed…